IBDEI3A1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,55067,0)
 ;;=D56.3^^256^2775^180
 ;;^UTILITY(U,$J,358.3,55067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55067,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,55067,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,55067,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,55068,0)
 ;;=D56.9^^256^2775^181
 ;;^UTILITY(U,$J,358.3,55068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55068,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,55068,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,55068,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,55069,0)
 ;;=M31.1^^256^2775^183
 ;;^UTILITY(U,$J,358.3,55069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55069,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,55069,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,55069,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,55070,0)
 ;;=D51.2^^256^2775^184
 ;;^UTILITY(U,$J,358.3,55070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55070,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,55070,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,55070,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,55071,0)
 ;;=D05.92^^256^2775^33
 ;;^UTILITY(U,$J,358.3,55071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55071,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,55071,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,55071,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,55072,0)
 ;;=D05.91^^256^2775^35
 ;;^UTILITY(U,$J,358.3,55072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55072,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,55072,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,55072,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,55073,0)
 ;;=D05.90^^256^2775^31
 ;;^UTILITY(U,$J,358.3,55073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55073,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,55073,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,55073,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,55074,0)
 ;;=D51.0^^256^2775^185
 ;;^UTILITY(U,$J,358.3,55074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55074,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,55074,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,55074,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,55075,0)
 ;;=D51.1^^256^2775^186
 ;;^UTILITY(U,$J,358.3,55075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55075,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,55075,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,55075,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,55076,0)
 ;;=D51.9^^256^2775^188
 ;;^UTILITY(U,$J,358.3,55076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55076,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,55076,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,55076,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,55077,0)
 ;;=D68.0^^256^2775^190
 ;;^UTILITY(U,$J,358.3,55077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55077,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,55077,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,55077,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,55078,0)
 ;;=C88.0^^256^2775^191
 ;;^UTILITY(U,$J,358.3,55078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55078,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,55078,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,55078,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,55079,0)
 ;;=C91.02^^256^2775^3
 ;;^UTILITY(U,$J,358.3,55079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55079,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,55079,1,4,0)
 ;;=4^C91.02
